Safety of Single Doses of CSL889 in Adult Patients With Sickle Cell Disease
Clinical trial NCT04285827 · COMPLETED
Trial details
- NCT number
- NCT04285827
- Sponsor
- CSL Behring
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-05-20
- Primary completion
- 2023-07-24
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.